Kodiak Sciences (KOD) Common Equity (2017 - 2026)

Kodiak Sciences (KOD) has 10 years of Common Equity data on file, last reported at $112.1 million in Q1 2026.

• Quarterly Common Equity rose 2.99% year-over-year to $112.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.1 million (up 2.99% YoY) and the FY2025 annual result came in at $157.4 million, up 4.72% from the prior year.
• Common Equity slipped to $112.1 million in Q1 2026, from $157.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $597.4 million in Q1 2022 to a low of $23.7 million in Q3 2025.
• A 5-year average of $271.0 million and a median of $241.2 million in 2024 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 4.72% in 2025, down 87.22% in 2025.
• Tracing KOD's Common Equity over 5 years: stood at $436.2 million in 2022, then tumbled by 39.06% to $265.8 million in 2023, then sank by 43.45% to $150.3 million in 2024, then increased by 4.72% to $157.4 million in 2025, then dropped by 28.77% to $112.1 million in 2026.
• The last three Common Equity figures came in at $112.1 million (Q1 2026), $157.4 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.